Medication delivery apparatus and system and methods for the use and assembly thereof

• US 9,700,689 B2
• Filed: 09/18/2013
• Issued: 07/11/2017
• Est. Priority Date: 05/21/2002
• Status: Active Grant

• Current Assignee: Trudell Medical International (Trudell Medical Limited)
• Original Assignee: Trudell Medical International (Trudell Medical Limited)
• Inventors: Bruce, Sarah, Schmidt, James N.
• Primary Examiner(s): Dixon, Annette
• Application Number:
  US14/030,690
• Publication Number:
  US 20140116436A1
• Time in Patent Office: 1,392 Days
• Field of Search: 12820014, 12820018, 12820023, 12820323, 12820324, 12820329, 12820523, 12820524, 12820624, 12820712
• CPC Class Codes: A61M 15/0016 located downstream of the dispenser, i.e. traversed by the product
• CPC Class Codes: A61M 15/0018 with exhalation check valves
• CPC Class Codes: A61M 15/0086 Inhalation chambers
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 16/06 Respiratory or anaesthetic masks
• CPC Class Codes: A61M 16/0616 with face sealing means comprising a flap or membrane projecting inwards, such that sealing increases with increasing inhalation gas pressure
• CPC Class Codes: A61M 16/14 by mixing different fluids, one of them being in a liquid phase
• CPC Class Codes: A61M 16/208 Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves
• CPC Class Codes: A61M 2205/583 by visual feedback
• CPC Class Codes: A61M 2207/00 Methods of manufacture, assembly or production
• CPC Class Codes: Y10T 29/49826 Assembling or joining

Abstract

A delivery system includes a holding chamber with first, second and third openings, and independently moveable first, second and third flow control members. A delivery system includes a holding chamber and a flow control member including a flap pivotable from an at rest position in a direction toward an outlet of a user interface and away from an output end of the holding chamber in response to a pressure being applied thereto.

Claims

1. A medication delivery system comprising:

a chamber housing comprising an exit port;

a patient interface releasably coupled to the chamber housing and comprising a mouthpiece defining an inhalation conduit and defining an opening positioned above the inhalation conduit;

a flow control member comprising a flap having a free end and an anchor portion formed along an end of the flap opposite the free end, wherein the flow control member is slideable from a non-engaged position, wherein the anchor portion is disengaged from the mouthpiece, to an engaged position, wherein the anchor portion is engaged with the mouthpiece and wherein the flap covers the opening, wherein the patient interface and flow control member define a self-contained unit when the flow control member is in the engaged position, wherein the self-contained unit is moveable between a disengaged position such that the self-contained unit is decoupled from the chamber housing, to an engaged position such that the self-contained unit is coupled to the chamber housing.

2. The medication delivery system of claim 1 wherein the anchor portion comprises a groove, and the mouthpiece comprises a ridge, wherein the ridge is received in the groove as the flow control member is slid to the engaged position.

3. The medication delivery system of claim 2 wherein the groove extends across a width of the anchor portion.

4. The medication delivery system of claim 1 wherein the anchor portion engages the mouthpiece with a snap-fit in the engaged position.

5. The medication delivery system of claim 1 wherein the free end of the flap is configured with a rounded edge.

6. The medication delivery system of claim 5 wherein the free end has a semi-circular shape.

7. A method for assembling a medication delivery system comprising:

providing a chamber housing comprising an exit port;

providing a patient interface comprising a mouthpiece defining an inhalation conduit and defining an opening positioned above the inhalation conduit;

providing a flow control member comprising a flap having a free end and an anchor portion formed along an end of the flap opposite the free end;

sliding the flow control member relative to the mouthpiece from a non-engaged position, wherein the anchor portion is disengaged from the mouthpiece, to an engaged position, wherein the anchor portion is engaged with the mouthpiece and wherein the flap covers the opening, wherein the patient interface and flow control member define a self-contained unit when the flow control member is in the engaged position; and

releasably coupling the self-contained unit to the chamber housing.

8. The method of claim 7 wherein sliding the flow control member from the non-engaged position to the engaged position comprises engaging a ridge formed on the mouthpiece with a groove formed on the anchor portion.

9. The method of claim 8 wherein the groove extends across a width of the anchor portion.

10. The method of claim 7 wherein sliding the flow control member from the non-engaged position to the engaged position comprises engaging the mouthpiece with the anchor portion by way of a snap-fit.

11. The method of claim 7 wherein the free end of the flap is configured with a rounded edge.

12. The method of claim 11 wherein the free end has a semi-circular shape.

13. A medication delivery system comprising:

a chamber housing comprising an exit port;

a patient interface coupled to the chamber housing and comprising a mouthpiece defining an inhalation conduit and defining a first opening positioned above the inhalation conduit;

a first flow control member disposed in the inhalation conduit;

a port coupled to the mouthpiece and disposed above the inhalation conduit, the port having a front portion communicating with the first opening, a rear portion having a second opening communicating with the ambient environment, and a stop disposed in the port between the first and second openings, the stop defining a third opening in the port, wherein the second opening is spaced apart from the first opening, and the third opening is spaced apart from the second opening; and

a second flow control member separate from the first flow control member and disposed in the port, wherein the second flow control member comprises a flap having a free end and an anchor portion formed along an end of the flap opposite the free end, the anchor portion non-moveably secured to the port, wherein the flap of the second flow control member is moveable within the port in response to a breathing cycle of a user, and wherein the flap of the second flow control member is biased toward the stop and covers the third opening in an at-rest position.

14. The medication delivery system of claim 13 wherein the stop has a vertical orientation.

15. The medication delivery system of claim 14 wherein the flap of the second flow control member is vertically oriented when in the at-rest position.

16. The medication delivery system of claim 13 wherein the third opening is circular.

17. The medication delivery system of claim 13 wherein the first flow control member is configured as a duckbill valve.

18. The medication delivery system of claim 13 wherein at least the front portion of the port is integrally formed with the patient interface.

19. The medication delivery system of claim 18 wherein the first opening is further defined by a bottom of the front portion at a location spaced apart from the stop.

20. The medication delivery system of claim 13 wherein the front and rear portions are configured as separate front and rear housings, wherein the rear housing is coupled to the front housing.

21. The medication delivery system of claim 13 wherein the rear portion of the port overlies a portion of the chamber housing spaced rearwardly from the exit port.

22. The medication delivery system of claim 21 wherein the second opening is spaced rearwardly from the exit port.

23. The medication delivery system of claim 13 wherein the front portion comprises a curved front wall facing a user when in use.

24. The medication delivery system of claim 13 wherein at least a portion of the port is transparent.

25. The medication delivery system of claim 13 wherein the free end of the flap is configured with a rounded edge.

26. The medication delivery system of claim 25 wherein the free end has a semi-circular shape.

27. The medication delivery system of claim 13 wherein the port is raised radially outwardly from an outer surface of the mouthpiece along only an upper portion of the mouthpiece.